Maternus-Kliniken AG

XETRA MAK.DE

Maternus-Kliniken AG Shareholders' Equity for the year ending December 31, 2023: USD -59.33 M

Maternus-Kliniken AG Shareholders' Equity is USD -59.33 M for the year ending December 31, 2023, a -41.11% change year over year. Shareholders' equity are the residual interest in the assets of a company after deducting liabilities, representing the shareholders' ownership claim.
  • Maternus-Kliniken AG Shareholders' Equity for the year ending December 31, 2022 was USD -42.05 M, a -32.64% change year over year.
  • Maternus-Kliniken AG Shareholders' Equity for the year ending December 31, 2021 was USD -31.70 M, a -2.14% change year over year.
  • Maternus-Kliniken AG Shareholders' Equity for the year ending December 31, 2020 was USD -31.04 M, a -74.62% change year over year.
  • Maternus-Kliniken AG Shareholders' Equity for the year ending December 31, 2019 was USD -17.77 M, a -186.27% change year over year.
Key data
Date Shareholders' Equity Minority Interest Total Equity Total Stockholders Equity and Liabilities
Market news
Loading...
SV Wall Street
XETRA: MAK.DE

Maternus-Kliniken AG

CEO Mr. Mario Augusto Ruano Wohlers
IPO Date May 21, 1999
Location Germany
Headquarters FranzOesische Strasse 53 - 55
Employees 1,452
Sector Healthcare
Industries
Description

Maternus-Kliniken Aktiengesellschaft operates retirement and nursing homes, rehabilitation clinics, and various service companies that operate in the field of geriatric care and rehabilitation medicine. The company also provides emergency call, assisted living, rehabilitation, and follow-up treatment services, as well as domestic, inpatient, short term, and handicapped care services. It operates approximately 23 facilities in Germany. The company was founded in 1877 and is headquartered in Berlin, Germany.

Similar companies

MZX.DE

Masterflex SE

USD 10.66

0.25%

RHK.DE

RHÖN-KLINIKUM AG

USD 14.98

-1.80%

LEI.DE

Leifheit AG

USD 16.80

0.87%

NXU.DE

Nexus AG

USD 71.79

0.83%

MED.DE

MEDICLIN AG

USD 3.10

-1.73%

StockViz Staff

February 6, 2025

Any question? Send us an email